FBIO Fortress Biotech, Inc.

1.62-0.05 (-2.99%)
Close: September 20, 2019

1.56-0.06 (-3.70%)
Pre-market

Quote

Previous Close
$1.62
Day Range
$1.60-$1.75
52 Week Range
$0.49-$2.59
Volume
462,503
Avg Volume
413,650
Dividend TTM
-
Ex-Dividend Date
-

Valuation

Market Cap
$111.85M
Enterprise Value (EV)
$108.24M
PE Ratio
-
EV/EBITDA
-0.92
Price/Sales
4.16
Price/Book
60.39
PEG Ratio
0.02

Financials

Revenue
$26.88M
Gross Profit
$19.36M
EBITDA
-$117.94M
EPS, ttm
-$1.57
Profit Margin
-
Revenue/Employee
$305.48K
Next Earnings Date
11/11/2019 (50 days)
Debt to Equity
4,293%
Debt
$79.50M
Cash
$83.11M
Net Debt
-

Performance

Beta
1.76
200 Day Moving Avg
$1.62
50 Day Moving Avg
$1.58
52 Week Change
2.53%
YTD Change
45.63%
1 Month Change
-10.00%
3 Month Change
-5.26%
6 Month Change
-18.18%
1 Year Change
2.53%
2 Year Change
-48.89%
5 Year Change
-49.17%

Share Count

Shares Outstanding
69.0M
Float
47.8M
Restricted Shares
21.3M
Restricted Shares, %
30.83%

Fortress Biotech, Inc. Company Details

Sector: Health Technology

Industry: Biotechnology

CEO: Lindsay Allan Rosenwald

Website: http://www.fortressbiotech.com

Description: Fortress Biotech, Inc. engages in the development and commercialization of novel pharmaceutical and biotechnology products. It operates through the following segments: Dermatology Product Sales, Pharmaceutical and Biotechnology Product Development, and National. The National segment consists of National Holdings Corporation, an independent brokerage company. The company was founded on June 28, 2006 in and is headquartered in New York, NY.

Employees: 88